NIPT (Non Invasive Prenatal Testing) at Chughtai Lab

NIPT (Non Invasive Prenatal Testing) at Chughtai Lab

Non-Invasive Prenatal Testing (NIPT) is an advanced, highly sophisticated screening method used to assess the risk of specific chromosomal abnormalities in a developing fetus. Performed through a simple maternal blood draw, this test analyzes cell-free DNA (cfDNA) circulating in the mother’s bloodstream. During pregnancy, tiny fragments of DNA from the placenta enter the maternal circulation. Because placental DNA is genetically identical to fetal DNA in the vast majority of cases, analyzing these fragments allows clinicians to screen for genetic conditions without risking the safety of the pregnancy. NIPT at Chughtai Lab represents a major milestone in modern prenatal care, offering expectant parents a safe, accurate, and early screening option.

The primary clinical value of NIPT lies in its exceptional sensitivity and specificity, particularly for common autosomal trisomies such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Unlike traditional first-trimester screening methods, which rely on maternal serum biomarkers and ultrasound measurements of nuchal translucency, NIPT directly analyzes genetic material. This direct analysis significantly reduces the false-positive rate, thereby preventing unnecessary invasive diagnostic procedures like amniocentesis or chorionic villus sampling (CVS), which carry a small but inherent risk of miscarriage. By providing highly reliable risk assessment as early as the 10th week of gestation, NIPT empowers families and healthcare providers with critical information to guide prenatal management and delivery planning.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure the accuracy of NIPT and a smooth testing experience. Patients should observe the following guidelines:

• Gestational Age Verification: The test must be performed only after completing at least 10 weeks of pregnancy. Testing too early may result in an insufficient amount of fetal DNA in the maternal blood, known as a low fetal fraction, which can lead to an inconclusive result.
• Ultrasound Confirmation: It is highly recommended to have a recent ultrasound scan before the test to confirm gestational age, verify fetal viability, and determine whether it is a singleton or multiple pregnancy (twins).
• No Fasting Required: There are no dietary restrictions before the test. You may eat and drink normally prior to your sample collection.
• Hydration: Drinking plenty of water before the blood draw is recommended, as good hydration helps make the veins more accessible for the phlebotomist.
• Medical History Documentation: Be prepared to provide accurate clinical details, including your exact gestational age, maternal weight, height, history of blood transfusions, organ transplants, immunotherapy, or stem cell therapy, as these factors can influence the analysis.
• Genetic Counseling: Discussing the test with your obstetrician or a genetic counselor prior to the blood draw is highly beneficial to understand the scope, limitations, and potential implications of the results.

During the Procedure

The collection process for NIPT at Chughtai Lab is straightforward, safe, and minimally invasive, closely resembling a routine blood test:

• Patient Positioning: You will be comfortably seated in a blood collection chair. The phlebotomist will verify your identity and confirm your clinical details.
• Sanitization: The skin over the selected vein, typically in the inner elbow area, will be thoroughly cleaned with an antiseptic solution to prevent contamination.
• Sample Collection: A small tourniquet is applied to the upper arm to make the veins more prominent. Using a sterile, single-use needle, the phlebotomist will draw approximately 7 to 10 milliliters of blood into a specialized cell-stabilizing tube.
• Specialized Equipment: Chughtai Lab uses dedicated blood collection tubes designed to preserve cell-free DNA and prevent maternal white blood cells from lysing, which would otherwise dilute the fetal DNA.
• Duration: The entire venipuncture procedure takes less than five minutes.
• Post-Collection Care: After removing the needle, gentle pressure is applied to the puncture site with a sterile cotton ball, followed by the application of a small bandage to prevent bruising.
• Safety and Comfort: The procedure carries zero risk of miscarriage or harm to the fetus. The only discomfort is a brief pinch during needle insertion.

When is a NIPT (Non Invasive Prenatal Testing) Performed?

Advanced Maternal Age (35 Years and Older)

The risk of chromosomal aneuploidies, particularly Trisomy 21 (Down syndrome), increases significantly with maternal age. For women who will be 35 years or older at the time of delivery, physicians routinely recommend NIPT as a primary screening tool. The test provides an exceptionally accurate risk assessment, helping older mothers avoid invasive diagnostic procedures unless absolutely necessary.

Abnormal First-Trimester Screening Results

When conventional first-trimester screening—such as the double marker biochemical test or ultrasound measurement of nuchal translucency—indicates an elevated risk for chromosomal abnormalities, NIPT is often requested as a secondary, highly sensitive screening step. It helps clarify the risk profile before deciding on invasive diagnostic testing.

Ultrasound Anomalies or Soft Markers

If a routine prenatal ultrasound reveals structural anomalies or soft markers associated with genetic syndromes (such as an absent nasal bone, increased nuchal fold, or cardiac focus), a physician may order NIPT. The test helps determine if these physical markers are linked to a chromosomal imbalance, aiding in comprehensive clinical decision-making.

Family History of Chromosomal Abnormalities

Expectant parents who have a personal or family history of genetic disorders, or who have previously had a pregnancy affected by a chromosomal aneuploidy, have an elevated risk of recurrence. In these cases, NIPT is performed early in pregnancy to screen for specific genetic conditions and provide early clinical insights.

Anxiety and Desire for Early Reassurance

Many expectant parents choose to undergo NIPT simply for peace of mind. Because the test offers a detection rate of over 99% for Down syndrome with an extremely low false-positive rate, it provides reliable reassurance early in the pregnancy, reducing parental anxiety and allowing for a more relaxed pregnancy experience.

What Does a NIPT (Non Invasive Prenatal Testing) Detect?

NIPT is designed to screen for a specific set of chromosomal variations by analyzing the relative proportion of cell-free DNA fragments. It can detect:

• Trisomy 21 (Down Syndrome): The presence of an extra copy of chromosome 21, which causes intellectual disability and potential physical anomalies.
• Trisomy 18 (Edwards Syndrome): An extra copy of chromosome 18, associated with severe developmental delays and structural abnormalities.
• Trisomy 13 (Patau Syndrome): An extra copy of chromosome 13, leading to severe intellectual and physical disabilities.
• Monosomy X (Turner Syndrome): A condition in females characterized by a missing X chromosome, leading to short stature and ovarian dysfunction.
• Klinefelter Syndrome (XXY): A condition in males characterized by an extra X chromosome, which can affect physical and cognitive development.
• Triple X Syndrome (XXX): An extra X chromosome in females, often presenting with mild or no physical symptoms.
• Jacobs Syndrome (XYY): An extra Y chromosome in males, typically associated with tall stature and mild learning difficulties.
• Fetal Fraction: The percentage of cell-free DNA in the maternal blood that originates from the placenta, which must be adequate (typically above 4%) for a reliable result.
• Microdeletions (Optional Panels): Small missing pieces of specific chromosomes, such as DiGeorge syndrome (22q11.2 deletion), which can cause heart defects and immune issues.
• Triploidy: A rare condition where the fetus has an entire extra set of chromosomes (69 chromosomes instead of 46).

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, the processing of molecular and genetic tests like NIPT is handled with the utmost precision and care. Because NIPT involves advanced Next-Generation Sequencing (NGS) and complex bioinformatics analysis, the turnaround time is typically between 7 to 10 working days. This timeframe ensures that the genetic data is thoroughly analyzed, verified, and reviewed by qualified clinical pathologists and genetic specialists.

Chughtai Lab offers highly convenient options for accessing your diagnostic reports. Once the analysis is complete and verified, patients receive an automated SMS notification. Reports can be downloaded directly from the official Chughtai Lab website by entering the patient ID and lab number. Additionally, reports are accessible through the Chughtai Lab mobile application, providing a secure, digital, and easily shareable format for your obstetrician.

NIPT (Non Invasive Prenatal Testing) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Chromosome 21 (Trisomy 21 Risk)	Low Risk (Negative)	High Risk (Positive for Down Syndrome)
Chromosome 18 (Trisomy 18 Risk)	Low Risk (Negative)	High Risk (Positive for Edwards Syndrome)
Chromosome 13 (Trisomy 13 Risk)	Low Risk (Negative)	High Risk (Positive for Patau Syndrome)
Sex Chromosome Aneuploidies	Normal XX (Female) or XY (Male)	Monosomy X, XXY, XXX, or XYY detected
Fetal Fraction	Adequate (Typically ≥ 4%)	Low Fetal Fraction (< 4%), requiring a redraw
Microdeletion Panels (If selected)	No microdeletions detected	Microdeletion detected (e.g., 22q11.2 deletion)
Triploidy Screening	Not detected	High risk of triploidy detected

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for NIPT (Non Invasive Prenatal Testing)?

• Experienced Healthcare Professionals: Your samples are processed and interpreted by highly trained molecular biologists and pathologists.
• Advanced Molecular Technology: Chughtai Lab utilizes state-of-the-art Next-Generation Sequencing (NGS) platforms for genetic testing.
• Patient-Focused Care: Dedicated support staff are available to guide you through the preparation, collection, and reporting process.
• Convenient Home Sample Collection: Chughtai Lab offers professional home sample collection services, allowing you to have your blood drawn in comfort.
• Secure Online Report Access: Easily download your reports via the Chughtai Lab website or mobile app anytime, anywhere.
• Extensive Diagnostic Network: With locations across major cities in Pakistan, accessing quality diagnostics is convenient and reliable.
• Strict Quality Control: Chughtai Lab adheres to international quality standards, ensuring highly accurate and reproducible results.
• Comprehensive Genetic Portfolio: Offering a wide range of molecular diagnostics to support maternal and fetal healthcare.